Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Cash from Financing Activities (2020 - 2023)

Terns Pharmaceuticals' Cash from Financing Activities history spans 4 years, with the latest figure at $13.9 million for Q4 2023.

  • For Q4 2023, Cash from Financing Activities fell 86.92% year-over-year to $13.9 million; the TTM value through Dec 2023 reached $42.0 million, down 74.89%, while the annual FY2025 figure was $743.5 million, 353.37% up from the prior year.
  • Cash from Financing Activities reached $13.9 million in Q4 2023 per TERN's latest filing, up from $20000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $135.2 million in Q1 2021 to a low of -$1.6 million in Q2 2021.
  • Average Cash from Financing Activities over 4 years is $28.6 million, with a median of $797000.0 recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: tumbled 109.42% in 2021, then surged 662212.5% in 2022.
  • A 4-year view of Cash from Financing Activities shows it stood at $68.6 million in 2020, then plummeted by 99.98% to $16000.0 in 2021, then soared by 662212.5% to $106.0 million in 2022, then tumbled by 86.92% to $13.9 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Cash from Financing Activities are $13.9 million (Q4 2023), $20000.0 (Q3 2023), and $489000.0 (Q2 2023).